S100A4 and neoplasm: Two additional EF-hand proteins with high structural homology were selected from the S100 family: S100A4 and S100B,58 both important pharmacological targets for cancer treatment.59 S100A4 is involved in tumour progression and metastasis and has many interacting partners.